S Verver
How can onchocerciasis elimination in Africa be accelerated? Modelling the impact of increased ivermectin treatment frequency and complementary vector control
Verver, S; Walker, M; Kim, Y E; Fobi, G; Tekle, A H; Zouré, H G M; Wanji, S; Boakye, D A; Kuesel, A C; De Vlas, S J; Boussinesq, M; Basáñez, M-G; Stolk, W A
Authors
M Walker
Y E Kim
G Fobi
A H Tekle
H G M Zouré
S Wanji
D A Boakye
A C Kuesel
S J De Vlas
M Boussinesq
M-G Basáñez
W A Stolk
Citation
Verver, S., Walker, M., Kim, Y. E., Fobi, G., Tekle, A. H., Zouré, H. G. M., …Stolk, W. A. (2018). How can onchocerciasis elimination in Africa be accelerated? Modelling the impact of increased ivermectin treatment frequency and complementary vector control. Clinical Infectious Diseases, 66(4), S267-S274. https://doi.org/10.1093/cid/cix1137
Journal Article Type | Article |
---|---|
Acceptance Date | May 30, 2018 |
Publication Date | Jun 1, 2018 |
Deposit Date | Mar 8, 2018 |
Publicly Available Date | Nov 21, 2020 |
Journal | CLINICAL INFECTIOUS DISEASES |
Print ISSN | 1058-4838 |
Publisher | Oxford University Press |
Peer Reviewed | Peer Reviewed |
Volume | 66 |
Issue | 4 |
Pages | S267-S274 |
DOI | https://doi.org/10.1093/cid/cix1137 |
Public URL | https://rvc-repository.worktribe.com/output/1387022 |
Files
11236.pdf
(1.7 Mb)
PDF
You might also like
Revisiting density-dependent fecundity in schistosomes using sibship reconstruction
(2021)
Journal Article
Designing antifilarial drug trials using clinical trial simulators
(2020)
Journal Article